You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IPI-Biotherapy

Showing 1 - 25 of 165
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Saint Petersburg, Cremona, Vilnius (REGN2810/ipi, REGN2810/chemo/ipi, Pembrolizumab)

Terminated
Has Results
  • Non-small Cell Lung Cancer
  • Saint Petersburg, Florida
  • +2 more
Oct 22, 2022

Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Head and Neck Carcinoma Trial in La Jolla (IPI-549)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +7 more
  • La Jolla, California
    UC San Diego Moores Cancer Center
Jul 20, 2022

Biotherapies, Rheumatology, Rheumatoid Arthritis Trial in Amiens (nursing consultation)

Active, not recruiting
  • Biotherapies
  • +2 more
  • nursing consultation
  • Amiens, Picardie, France
    CHU Amiens Picardie
Feb 28, 2023

Endoscopy Trial in Istanbul (gastroscopy)

Recruiting
  • Endoscopy
  • gastroscopy
  • Istanbul, Gaziosmanpaşa, Turkey
    Gaziosmanpaşa TREH
Apr 13, 2023

Integrated Pulmonary Index asDeterminate of Weaning Success

Withdrawn
  • Respiratory Insufficiency
    • Chicago, Illinois
      Rush University Medical Center- Rush Children's Hospital
    Dec 23, 2022

    Active Non-anterior Non-infectious Uveitis Trial (Baricitinib 4 MG)

    Not yet recruiting
    • Active Non-anterior Non-infectious Uveitis
    • Baricitinib 4 MG
    • (no location specified)
    Dec 7, 2022

    Advanced Solid Tumors (Part A/B/C/D), NSCLC (Part E), Melanoma (Part E) Trial in United States (IPI-549 (eganelisib), Nivolumab)

    Active, not recruiting
    • Advanced Solid Tumors (Part A/B/C/D)
    • +7 more
    • San Diego, California
    • +10 more
    Apr 1, 2022

    Immune-related Adverse Event, Diarrhea, Advanced Melanoma Trial in Edmonton (Mesalamine)

    Not yet recruiting
    • Immune-related Adverse Event
    • +3 more
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    Dec 15, 2022

    Melanoma Stage IV, Melanoma Stage III, Immunetherapy Trial (nivolumab)

    Not yet recruiting
    • Melanoma Stage IV
    • +3 more
    • (no location specified)
    Dec 14, 2022

    Metastatic Urothelial Carcinoma Trial in Tampa, Boston (Ipilimumab, Nivolumab, Sacituzumab govitecan)

    Recruiting
    • Metastatic Urothelial Carcinoma
    • Tampa, Florida
      Moffitt Cancer Center
    Jan 24, 2023

    Family Planning, Contraception, PostPartum Trial in Wailuku, Chicago, New York (LINCC intervention - enable co-schedule feature)

    Recruiting
    • Family Planning
    • +2 more
    • LINCC intervention - enable co-schedule feature
    • Wailuku, Hawaii
    • +4 more
    Nov 18, 2022

    Monitored Anesthesia Care, Respiratory Monitoring Trial in Istanbul (Integrated Pulmonary Index (IPI) monitoring, propofol,

    Completed
    • Monitored Anesthesia Care
    • Respiratory Monitoring
    • Integrated Pulmonary Index (IPI) monitoring
    • +2 more
    • Istanbul, Pendik, Turkey
      Marmara University School of Medicine
    Mar 14, 2022

    Monitored Anesthesia Care, Respiratory Monitoring Trial in Istanbul (Integrated Pulmonary Index (IPI) monitoring, propofol,

    Completed
    • Monitored Anesthesia Care
    • Respiratory Monitoring
    • Integrated Pulmonary Index (IPI) monitoring
    • +2 more
    • Istanbul, Pendik, Turkey
      Marmara University School of Medicine
    Mar 14, 2022

    Lymphoma, B-Cell Trial in San Antonio (R-Chop and Roflumilast)

    Not yet recruiting
    • Lymphoma, B-Cell
    • R-Chop and Roflumilast
    • San Antonio, Texas
      Mays Cancer Center, UT Health San Antonio
    Mar 31, 2023

    Frontline of ASCT in High-risk DLBCL

    Recruiting
    • Diffuse Large B Cell Lymphoma
      • Beijing, Beijing, China
        Peking University People's Hospital
      Apr 26, 2023

      Breast Cancer, Chemo-Related Cognitive Impairment Trial in Miami (Individualized Piano Keyboard Instruction)

      Completed
      • Breast Cancer
      • Chemotherapy-Related Cognitive Impairment
      • Individualized Piano Keyboard Instruction
      • Miami, Florida
        University of Miami
      Jun 9, 2023

      Integrated Pulmonary Index During Cesarean Section Under Spinal

      Not yet recruiting
      • Intraoperative Hypotension
      • Capnometry Monitorization
      • (no location specified)
      Feb 11, 2022

      Monitored Anesthesia Care Trial in Samsun (Smart Capnography™, Microstream®)

      Completed
      • Monitored Anesthesia Care
      • Smart Capnography™, Microstream®
      • Samsun, Turkey
        Samsun Research and Education Hospital
      Apr 26, 2022

      DLBCL Germinal Center B-Cell Type Trial in China (Selinexor, Rituximab, Cyclophosphamide)

      Recruiting
      • DLBCL Germinal Center B-Cell Type
      • Guangzhou, Guangdong, China
      • +5 more
      Aug 16, 2022

      Thoracic Surgery Patients

      Completed
      • Postoperative Complications
      • Monitoring
      • integrated pulmonary index monitor
      • Adana, Turkey
        Mediha Türktan
      May 10, 2022

      Nivolumab, Ipilimumab, and Chemotherapy in Non-small Cell Lung

      Not yet recruiting
      • Carcinoma, Non-Small-Cell Lung
        • Athens, Greece
          Local Institution - 0001
        Oct 26, 2022

        Bladder Cancer, Urothelial Carcinoma, Solid Tumor Trial in Worldwide (IPI-549 (eganelisib), Nivolumab, Placebos)

        Active, not recruiting
        • Bladder Cancer
        • +3 more
        • IPI-549 (eganelisib)
        • +2 more
        • Fort Wayne, Indiana
        • +28 more
        Apr 1, 2022

        Atypical Teratoid Rhabdoid Tumor, INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors, SMARCA4-deficient Primary CNS Malignant

        Recruiting
        • Atypical Teratoid Rhabdoid Tumor
        • +6 more
        • Boston, Massachusetts
        • +1 more
        Jan 23, 2023

        Neutrophils and Eosinophils in Severe Asthma Treated With

        Not yet recruiting
        • Asthma
          • Paris, France
            Hôpital Bichat-Claude Bernard
          Jul 25, 2023

          Chronic Lymphocytic Leukemia Trial in Boston (IPI-145, Fludarabine, Cyclophosphamide)

          Active, not recruiting
          Has Results
          • Chronic Lymphocytic Leukemia
          • Boston, Massachusetts
          • +1 more
          Mar 10, 2022